E31.0
Autoimmune polyglandular failure
Clinical Classification Guidelines
Inclusion Terms
- Schmidt's syndrome
Medical Intelligence & Overview
Autoimmune polyglandular failure, also known as Schmidt's syndrome, is a rare condition where the body's immune system mistakenly attacks multiple endocrine glands. This results in the diminished function of these glands, leading to various hormone deficiencies. The condition often involves the simultaneous or sequential development of autoimmune diseases affecting the adrenal glands, thyroid, and other endocrine organs. Recognizing the symptoms early and understanding its causes can help in managing this complex disorder effectively.
Causes & Symptoms
Clinical Causes: Genetic predisposition: Certain genes, especially HLA genes, increase susceptibility. Autoimmune response: The immune system erroneously targets the body's own endocrine tissues. Environmental factors: Infections or other environmental triggers may play a role, though these are less well understood. Family history: A family history of autoimmune disorders increases risk.
Key Symptoms: Fatigue and weakness Unexplained weight loss or gain Low blood pressure Muscle and joint pains Skin darkening (especially with Addison's disease features) Hypoglycemia (low blood sugar levels) Persistent gastrointestinal issues like nausea or diarrhea Electrolyte imbalances Thyroid irregularities such as symptoms of hypothyroidism or hyperthyroidism Signs of adrenal insufficiency, including dizziness and fainting
Diagnostic & Treatment
Diagnosis Path: - Comprehensive medical history and physical examination to identify associated autoimmune conditions.
Treatment Protocols: - Patient education: Important for recognizing symptoms of hormonal imbalances and avoiding triggers that could exacerbate the condition.
Clinical Advice & FAQs
Billing Guidance
Is E31.0 a billable ICD-10 code?
Yes, E31.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report E31.0?
Clinical documentation must specify the nature of Autoimmune polyglandular failure and any associated comorbidities for accurate reporting.
Cite this Clinical Reference